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By  comparison  with  the  B  cell  of the  endocrine
pancreas,  the  A  cell  has  been  little  studied  both
in  the normal  and  in pathologic  states.  Recently,
however,  several  publications  have  been  devoted
to A-cell morphology  and secretory  cycle  (1),  and
to  the  still  controversial  distinction  between
several  A-cell  types  (2).  Furthermore,  with  the
availability  of  the  immunoassay  procedures  for
glucagon  (3),  dynamic  studies  of glucagon  secre-
tion  have  become  possible.  The  suggestion  has
been  made  that glucagon  not only  opposes insulin
action  but  also  favors  it  through  stimulation  of
insulin  release  (4).  This  double  relationship  pro-
posed  between  the  two  major  types  of endocrine
pancreatic  cells  prompts us to report  on a  striking
increase  in  A-cell  lysosomes  which  we  have  ob-
served  in  two  types  of diabetes  in  animals:  the
spontaneous  diabetes  of  spiny  mice  (Acomys
cahirinus) and  the  experimental  diabetes  resulting
from  the  injection  of  streptozotocin  in  rats.  In
both  instances,  the  increased  A-cell  lysosomes
were  associated  with  evidence  for  lysis  of alpha
granules.
Acomys  cahirinus  is  a  small  rodent  living  in
semidesertic  regions  of the  southeastern  Mediter-
ranean  region. All specimens which we have exam-
ined  exhibited  marked  congenital  hyperplasia  of
the  islets  of  Langerhans  (5).  Diabetes  occurred
spontaneously  in  approximately  15%  and  was
either  intermittent  or,  in  most  instances,  per-
sistent.  It  was  characterized  by  hyperglycemia,
decreased  levels  of  immunoreactive  insulin  in
462  B  R  I  E  F  N  O  T  E  SFIGURE  1  Adult diabetic  spiny mIouse.  In  the center part of all  A cell,  where  lysosomes  of several  types
may  be  seel;  some contain  secretory  granules  (sg) still  recognizable  at different  stages  of  degradation
(lb);  others contain heterogenous  material.  G,  Golgi  complex;  n, nucleus; B, parts  of B  cells, filled  with
glycogen.  Fixation in  2%  osmium  tetroxide  in  0.13  M phosphate  buffer.  Epon  embedding.  Lead stain.
X  26,000.
463FIGURE  2  A cell from diabetic rat,  3  months after the intravenous  injection  of 45 mg/kg streptozotocin.
Secretory  granules  are  recognizable  within  several  Iytic  bodies  (lb).  C,  capillary.  m,  mitochondria.  n,
nucleus.  G,  Golgi complex  of an exocrine  cell.  Perfusion with  glutaraldehyde  and  postfixation  in 2%  os-
mium tetroxide.  Epon embedding.  Lead stain.  X  20,000.
FIGURES 3 and 4  Diabetic  rat, 3  wk  after the  intravenous  injection  of  55 mg/kg streptozotocin.  Lytic
bodies  contain up to  five  secretory  granules.  Fixation in  2 % osmium  tetroxide buffered  with s-collidine.
Epon embedding.  Lead  stain. Fig. 3,  X 38,000; Fig. 4,  X  47,000.
FIGURE 5  Diabetic rat, 3  wk after the intravenous injection of 55 mg/kg streptozotocin.  Residual body.
Fixation in 2%  osmium tetroxide buffered with s-collidine.  Epon embedding. Lead stain.  X 45,000.
464  B  R  I  E  F  N  T  E  Splasma  and  pancreas,  and  finally  by  ketonuria.
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Streptozotocin  is  a  N-nitroso  derivative  of  glu-
cosamine  and  has  antibiotic  and  antitumoral
properties.  It  is  a  potent  diabetogenic  agent  (6)
as  a  result  of  rapid,  irreversible,  and  specific
cytotoxicity  limited  to the  B  cells  of the  pancreas
(7).  Intravenous  injection  of a  single  dose  of 45-
65  mg/kg  streptozotocin  is  followed  after  24  hr
by  a  permanent  diabetic  state,  characterized  by
hyperglycemia  and  reduction  of  the  pancreatic
insulin content  to 5-10%  of normal  (7).  Granulo-
lysis  in  A  cells  was noticed  as early  as  3 wk  after
the  appearance  of diabetes  and  was  still  present
after  9 months  of untreated diabetes.
In  both  types  of  diabetic  animals,  electron
microscopic  study  of  the  endocrine  pancreatic
A  cells  revealed  the  frequent  occurrence  of cyto-
plasmic  bodies  containing  granules  easily  identi-
fiable  as  alpha granules  by  their  shape,  size,  and
density  (Figs.  1-4).  The  number  of  granules
within  these bodies  varied from one  to five.  These
granules  appeared  to  undergo  gradual  degrada-
tion,  with  different  stages  being  simultaneously
detectable  within  any one  cell and even  the same
body.  The  final  product  of granular  degradation
was  bodies  filled  with  very  fine  granulations  of
varying  densities.  We  suggest  that  these  bodies
are to  be  considered  as  lysosomes,  with sequestra-
tion  of  granules  occurring  in  dense  bodies  and
subsequent  evolution  through  autolysosomes  to
residual  bodies  (Fig.  5)  (8).  On  the  other  hand,
autophagic  vacuoles  containing  other  cellular
organelles such  as mitochondria or ribosomes were
not  seen.  Nor  were  there  clear-cut  signs  of  in-
creased protein  synthesis.
A-cell  lysosomes  have  also  been  observed  in
metabolically  normal  rats  and  mice.  However,
they  were  much  less  numerous  and  did  not,  as  a
rule,  show  evidence  of  granulolysis.  It  would
seem  likely,  therefore,  that  the  formation  of
granulolytic  lysosomes  in  endocrine  A  cells  of the
pancreas  is  somehow  enhanced  by the  endocrine
and  metabolic  derangements  associated  with  the
diabetic  state.  A  direct  action  of  streptozotocin
appears  unlikely,  since  the  increase  in  A-cell
lysosomes  occurs  weeks  after  the  administration
of the drug  and,  most significantly,  since it  is  also
seen  in spontaneous  diabetes  in  spiny  mice,  with-
out any  preceding  or  concomitant  therapy  what-
ever.
As to the function of these granulolytic  autolyso-
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somes,  we  can only speculate,  of course.  However,
it would seem reasonable  to mention three possible
hypotheses  within  the  wider  framework  of  the
probable  functions  of  autolysosomes  in  general,
as  recently  reviewed  by  de  Duve  and  Wattiaux
(8).  Firstly,  lysosomal  granulolysis  could  favor
cellular  dedifferentiation,  either  preceding  and
leading  to  cellular  destruction  or  returning  the
cell  to a potentially  more versatile state. A similar
mechanism has been invoked  as an  explanation  of
the  appearance  of  "mixed"  or  "intermediate"
endocrine-exocrine  cells  in  both  normal  and
diabetic  spiny  mice  (9)  and  in  rats  with chronic
streptozotocin-induced  diabetes.2 Secondly,  lyso-
somal  granulolysis  might  represent  solubilization
of stored  hormone  prior to  its secretion,  as  in the
case  of  the  mobilization  of  thyroglobulin  from
thyroidal  colloid.  However,  evidence  for  such  a
release  mechanism  has  never  been  reported  for
either pancreatic  A or  B  cells  and  it would  seem
unlikely  that  chronic  systemic  hyperglycemia
represents  a  major  stimulus  to  the  secretion  of
pancreatic  glucagon  (10).  Also,  increased  lyso-
somal  granulolysis  was  not  associated  with  mor-
phological  evidence  for  increased  protein  secre-
tion in  A  cells.
Thirdly,  in  our  present  view,  the  most  attrac-
tive  hypothesis  would  assign  to  the  granulolytic
lysosomes  the  function  of  participating  in  the
destruction  of an  unneeded  secretory  product,  as
might  be  true  for  glucagon  in  the  presence  of
chronic  hyperglycemia  and  lack  of  pancreatic
insulin.  While  atrophy  of A  cells  and  decreased
glucagon  secretion  are  not  generally  accepted
concomitants  of  spontaneous  or  experimental
diabetes,  a  few recent  reports on  alloxanized  rats
(11)  and  diabetic  Chinese  hamsters  (12)  lend
some  support  to  this  hypothesis.  That  lysosomes
may  play  an  important  role  in  the  involution  of
no  longer  stimulated  secretory  cells  has  been
clearly  demonstrated  for pituitary  MT  cells  after
cessation  of lactation  (13).
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